{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:37:37Z","timestamp":1790638657065,"version":"4.1.0"},"reference-count":224,"publisher":"Elsevier","isbn-type":[{"value":"9780128117385","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.pbr.2016.11.003","type":"book-chapter","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T15:32:42Z","timestamp":1484667162000},"page":"99-132","source":"Crossref","is-referenced-by-count":63,"title":["Ex vivo gene therapy for the treatment of neurological disorders"],"prefix":"10.1016","author":[{"given":"Genevieve","family":"Gowing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soshana","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive N.","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pbr.2016.11.003_bb0005","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/STROKEAHA.115.009854","article-title":"Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke","volume":"46","author":"Acosta","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0010","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbadis.2014.08.010","article-title":"Sporadic and hereditary amyotrophic lateral sclerosis (ALS)","volume":"1852","author":"Ajroud-Driss","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.stemcr.2015.01.013","article-title":"A transposon-mediated system for flexible control of transgene expression in stem and progenitor-derived lineages","volume":"4","author":"Akhtar","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0020","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jalz.2015.12.014","article-title":"Molecular mechanism of prion-like tau-induced neurodegeneration","volume":"12","author":"Alonso","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0025","doi-asserted-by":"crossref","first-page":"26417","DOI":"10.3390\/ijms161125961","article-title":"Alzheimer's disease: mechanism and approach to cell therapy","volume":"16","author":"Amemori","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0030","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/brain\/awr094","article-title":"Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain","volume":"134","author":"Andres","year":"2011","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/096368970000900108","article-title":"Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease","volume":"9","author":"Armstrong","year":"2000","journal-title":"Cell Transplant."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0040","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0045","first-page":"1","article-title":"Potential for stem cells therapy in Alzheimer's disease: do neurotrophic factors play critical role?","volume":"13","author":"Bali","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0050","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.5966\/sctm.2014-0121","article-title":"Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines","volume":"3","author":"Barrett","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/mt.2013.281","article-title":"Parkinson's disease gene therapy: success by design meets failure by efficacy","volume":"22","author":"Bartus","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0060","doi-asserted-by":"crossref","first-page":"19969","DOI":"10.1038\/srep19969","article-title":"Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells","volume":"6","author":"Bassuk","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0065","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.gt.3302679","article-title":"Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates","volume":"13","author":"Behrstock","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jneumeth.2014.03.005","article-title":"In vivo tracking of human neural progenitor cells in the rat brain using bioluminescence imaging","volume":"228","author":"Bernau","year":"2014","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3727\/096368915X688614","article-title":"In vivo tracking of human neural progenitor cells in the rat brain using magnetic resonance imaging is not enhanced by ferritin expression","volume":"25","author":"Bernau","year":"2016","journal-title":"Cell Transplant."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0085","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1042\/BST20140171","article-title":"The contribution of astrocytes to Alzheimer's disease","volume":"42","author":"Birch","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0090","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/scrt440","article-title":"Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models","volume":"5","author":"Blurton-Jones","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2012.04.002","article-title":"Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into parkinsonian mice","volume":"236","author":"Bye","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0105","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jneumeth.2007.02.022","article-title":"Lentiviral vector-mediated genetic modification of human neural progenitor cells for in gene therapy","volume":"163","author":"Capowski","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/exnr.1999.7098","article-title":"In vitro expansion of a multipotent population of human neural progenitor cells","volume":"158","author":"Carpenter","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0115","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/mt.2015.8","article-title":"Controlled striatal DOPA production from a gene delivery system in a rodent model of Parkinson's disease","volume":"23","author":"Cederfjall","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0120","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3727\/096368912X657323","article-title":"Therapeutic effect of BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) in a rodent model of middle cerebral artery occlusion","volume":"22","author":"Chang","year":"2013","journal-title":"Cell Transplant."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.05.100","article-title":"Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats","volume":"1284","author":"Chen","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.expneurol.2014.06.022","article-title":"Intrastriatal GDNF gene transfer by inducible lentivirus vectors protects dopaminergic neurons in a rat model of parkinsonism","volume":"261","author":"Chen","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0135","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.stem.2016.03.014","article-title":"Chemical control of grafted human PSC-derived neurons in a mouse model of Parkinson's disease","volume":"18","author":"Chen","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0140","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1073\/pnas.0904239106","article-title":"Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration","volume":"106","author":"Cicchetti","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ana.24174","article-title":"Mutant huntingtin is present in neuronal grafts in Huntington disease patients","volume":"76","author":"Cicchetti","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0150","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nrn2938","article-title":"Neural stem cell systems: physiological players or in vitro entities?","volume":"11","author":"Conti","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/7901","article-title":"A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors","volume":"17","author":"Corti","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0160","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington's disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0165","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s12015-010-9227-1","article-title":"Differentiated mesenchymal stem cells for sciatic nerve injury","volume":"7","author":"Dadon-Nachum","year":"2011","journal-title":"Stem Cell Rev."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0170","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2016.06.014","article-title":"Insights on the pathophysiology of Alzheimer's disease: the crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system","volume":"68","author":"Da Mesquita","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.arr.2016.01.006","article-title":"Opportunities and challenges in developing relevant animal models for Alzheimer's disease","volume":"26","author":"De Felice","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nan.12298","article-title":"Review: sporadic Parkinson's disease: development and distribution of alpha-synuclein pathology","volume":"42","author":"Del Tredici","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0185","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.addr.2014.11.011","article-title":"The ethics of stem cells revisited","volume":"82\u201383","author":"de Miguel-Beriain","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0190","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4103\/1673-5374.182682","article-title":"Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells","volume":"11","author":"Deng","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.20901","article-title":"Recovery from paralysis in adult rats using embryonic stem cells","volume":"60","author":"Deshpande","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","article-title":"Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease","volume":"214","author":"Dey","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/glia.10116","article-title":"Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells","volume":"40","author":"Dietrich","year":"2002","journal-title":"Glia"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.24332","article-title":"A large animal model of spinal muscular atrophy and correction of phenotype","volume":"77","author":"Duque","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2007.09.022","article-title":"Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease","volume":"209","author":"Ebert","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.expneurol.2010.03.005","article-title":"Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease","volume":"224","author":"Ebert","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0225","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.scr.2013.01.009","article-title":"EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs","volume":"10","author":"Ebert","year":"2013","journal-title":"Stem Cell Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.111","article-title":"Genome editing: the road of CRISPR\/Cas9 from bench to clinic","volume":"48","author":"Eid","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0235","doi-asserted-by":"crossref","first-page":"541259","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington's disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0240","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3727\/096368908784423300","article-title":"GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys","volume":"17","author":"Emborg","year":"2008","journal-title":"Cell Transplant."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0245","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nrneurol.2016.107","article-title":"Prevention of stroke: a strategic global imperative","volume":"12","author":"Feigin","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0250","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2217\/rme.15.25","article-title":"Developing stem cell therapies for juvenile and adult-onset Huntington's disease","volume":"10","author":"Fink","year":"2015","journal-title":"Regen. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0255","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0079-6123(08)62664-3","article-title":"Therapeutic effects of human fetal dopamine cells transplanted in a patient with Parkinson's disease","volume":"82","author":"Freed","year":"1990","journal-title":"Prog. Brain Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0260","doi-asserted-by":"crossref","first-page":"13877","DOI":"10.1073\/pnas.97.25.13877","article-title":"Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology","volume":"97","author":"Freeman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0265","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1073\/pnas.91.11.5104","article-title":"Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat","volume":"91","author":"Frim","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0270","article-title":"Review: astrocytes in Alzheimer's disease and other age-associated dementias; a supporting player with a central role","author":"Garwood","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0275","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0280","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1212\/WNL.0000000000002889","article-title":"Transplantation of spinal cord-derived neural stem cells for ALS: analysis of phase 1 and 2 trials","volume":"87","author":"Glass","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2013.03.016","article-title":"Mesenchymal stem cells and neuroregeneration in Parkinson's disease","volume":"247","author":"Glavaski-Joksimovic","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0290","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3727\/096368909X470801","article-title":"Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors","volume":"18","author":"Glavaski-Joksimovic","year":"2009","journal-title":"Cell Transplant."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0295","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/jnr.22435","article-title":"Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease","volume":"88","author":"Glavaski-Joksimovic","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0300","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.stemcr.2015.09.008","article-title":"Neural stem cells rescue cognitive and motor dysfunction in a transgenic model of dementia with lewy bodies through a BDNF-dependent mechanism","volume":"5","author":"Goldberg","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0305","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s13311-011-0068-7","article-title":"Stem cell transplantation for motor neuron disease: current approaches and future perspectives","volume":"8","author":"Gowing","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0310","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","article-title":"Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease","volume":"15","author":"Grealish","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0315","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.tins.2015.08.008","article-title":"Innate immunity fights Alzheimer's disease","volume":"38","author":"Guillot-Sestier","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0320","doi-asserted-by":"crossref","first-page":"155ra137","DOI":"10.1126\/scitranslmed.3004373","article-title":"Neural stem cell engraftment and myelination in the human brain","volume":"4","author":"Gupta","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0325","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0330","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nn863","article-title":"Dyskinesias following neural transplantation in Parkinson's disease","volume":"5","author":"Hagell","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0335","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.brainres.2015.06.035","article-title":"Neural and glial progenitor transplantation as a neuroprotective strategy for amyotrophic lateral sclerosis (ALS)","volume":"1628","author":"Haidet-Phillips","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0340","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.celrep.2014.05.027","article-title":"Long-term health of dopaminergic neuron transplants in Parkinson's disease patients","volume":"7","author":"Hallett","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0345","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0350","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jcyt.2015.02.001","article-title":"Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease","volume":"17","author":"Han","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0355","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1073\/pnas.0401103101","article-title":"Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats","volume":"101","author":"Harper","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0360","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jcyt.2016.08.007","article-title":"Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis","volume":"18","author":"Harris","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0365","doi-asserted-by":"crossref","first-page":"998","DOI":"10.5966\/sctm.2015-0050","article-title":"Low-dose irradiation enhances gene targeting in human pluripotent stem cells","volume":"4","author":"Hatada","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042614","article-title":"Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation","volume":"7","author":"Hefferan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0375","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/gt.2016.13","article-title":"Mifepristone-inducible transgene expression in neural progenitor cells in vitro and in vivo","volume":"23","author":"Hjelm","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0380","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuroscience.2015.07.014","article-title":"GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease","volume":"303","author":"Hoban","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0385","first-page":"158","article-title":"Behavioural effects of genetically engineered cells releasing dopa and dopamine after intracerebral grafting in a rat model of Parkinson's disease","volume":"85","author":"Horellou","year":"1991","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0390","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/jnr.21056","article-title":"Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat","volume":"84","author":"Horita","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0395","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12035-009-8097-5","article-title":"Targeting glial cells to elucidate the pathogenesis of Huntington's disease","volume":"41","author":"Hsiao","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0400","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/gt.2009.80","article-title":"Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice","volume":"16","author":"Hwang","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0405","doi-asserted-by":"crossref","first-page":"136","DOI":"10.14802\/jmd.16029","article-title":"Applications of CRISPR\/Cas9 for gene editing in hereditary movement disorders","volume":"9","author":"Im","year":"2016","journal-title":"J. Mov. Disord."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0410","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1101\/gad.10.24.3129","article-title":"Single factors direct the differentiation of stem cells from the fetal and adult central nervous system","volume":"10","author":"Johe","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0415","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0420","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1523\/JNEUROSCI.12-07-02849.1992","article-title":"Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats","volume":"12","author":"Kawaja","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0425","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1523\/JNEUROSCI.0942-10.2010","article-title":"Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF","volume":"30","author":"Kells","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0430","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm0698-727","article-title":"Functional integration of striatal allografts in a primate model of Huntington's disease","volume":"4","author":"Kendall","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0435","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/hum.2005.16.509","article-title":"GDNF delivery using human neural progenitor cells in a rat model of ALS","volume":"16","author":"Klein","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0440","article-title":"Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors","author":"Knippenberg","year":"2015","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0445","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.stemcr.2014.05.017","article-title":"Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice","volume":"3","author":"Kondo","year":"2014","journal-title":"Stem Cell Reports"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0450","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3727\/000000004783983350","article-title":"Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke","volume":"13","author":"Kondziolka","year":"2004","journal-title":"Cell Transplant."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0455","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3171\/jns.2005.103.1.0038","article-title":"Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial","volume":"103","author":"Kondziolka","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0460","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1073\/pnas.1606342113","article-title":"Fetal grafts for Parkinson's disease: decades in the making","volume":"113","author":"Kordower","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0465","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.nbd.2011.05.001","article-title":"Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat","volume":"43","author":"Kordower","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0470","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/mt.2013.108","article-title":"Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model","volume":"21","author":"Krakora","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0475","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.neuro.051508.135600","article-title":"The glial nature of embryonic and adult neural stem cells","volume":"32","author":"Kriegstein","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0480","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12015-010-9141-6","article-title":"Stem\/precursor cell-based CNS therapy: the importance of circumventing immune suppression by transplanting autologous cells","volume":"6","author":"Kulbatski","year":"2010","journal-title":"Stem Cell Rev."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0485","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ymthe.2004.09.020","article-title":"Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model","volume":"11","author":"Kurozumi","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0490","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbmt.2013.11.001","article-title":"Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients","volume":"20","author":"Kurtzberg","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0495","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0500","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cellsig.2015.02.018","article-title":"Growth factor treatment to overcome Alzheimer's dysfunctional signaling","volume":"27","author":"Lauzon","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0505","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neurobiolaging.2010.03.024","article-title":"Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation","volume":"33","author":"Lee","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0510","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3727\/096368912X638964","article-title":"Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in the mouse with ibotenic acid-induced cognitive dysfunction","volume":"21","author":"Lee","year":"2012","journal-title":"Cell Transplant."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025968","article-title":"Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS","volume":"6","author":"Lepore","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0520","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1523\/JNEUROSCI.15-12-07810.1995","article-title":"Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease","volume":"15","author":"Levivier","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0525","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2015.06.053","article-title":"Regenerative cellular therapies for neurologic diseases","volume":"1638","author":"Levy","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0530","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/scrt421","article-title":"Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis","volume":"5","author":"Lewis","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0535","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","article-title":"AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial","volume":"10","author":"LeWitt","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0540","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1073\/pnas.1605245113","article-title":"Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0545","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1172\/JCI40543","article-title":"Stem cells in human neurodegenerative disorders\u2014time for clinical translation?","volume":"120","author":"Lindvall","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0550","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0079-6123(08)62666-7","article-title":"Neural transplantation in Parkinson's disease: the Swedish experience","volume":"82","author":"Lindvall","year":"1990","journal-title":"Prog. Brain Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0555","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14712598.2015.995086","article-title":"Viral vector-mediated transgenic cell therapy in regenerative medicine: safety of the process","volume":"15","author":"Liu","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0560","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000430356","article-title":"Therapeutic effects of transplantation of as-MiR-937-expressing mesenchymal stem cells in murine model of Alzheimer's disease","volume":"37","author":"Liu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0565","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9-mediated editing of germline DNA","volume":"345","author":"Long","year":"2014","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0570","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3727\/096368909X12483162197123","article-title":"Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells","volume":"18","author":"Lopez-Gonzalez","year":"2009","journal-title":"Cell Transplant."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0575","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/stem.1933","article-title":"Autocrine production of IGF-I increases stem cell-mediated neuroprotection","volume":"33","author":"Lunn","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0580","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneuro0355","article-title":"Mechanisms of disease: astrocytes in neurodegenerative disease","volume":"2","author":"Maragakis","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0585","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/hgtb.2013.026","article-title":"Spatiotemporal control of vascular endothelial growth factor expression using a heat-shock-activated, rapamycin-dependent gene switch","volume":"24","author":"Martin-Saavedra","year":"2013","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0590","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cne.20176","article-title":"Human neural stem cell transplants improve motor function in a rat model of Huntington's disease","volume":"475","author":"McBride","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0595","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5966\/sctm.2015-0103","article-title":"Human cortical neural stem cells expressing insulin-like growth factor-I: a novel cellular therapy for Alzheimer's disease","volume":"5","author":"McGinley","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0600","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/glia.23022","article-title":"Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease","volume":"64","author":"Meunier","year":"2016","journal-title":"Glia"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0605","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1227\/01.NEU.0000290907.30814.42","article-title":"Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia","volume":"61","author":"Miki","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0610","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0615","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jnc.13411","article-title":"The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease","volume":"136","author":"Minter","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0620","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/cgt.2015.68","article-title":"PiggyBac as a novel vector in cancer gene therapy: current perspective","volume":"23","author":"Mirzaei","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0625","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/rej.2011.1209","article-title":"Current advances in intravascular administration of stem cells for neurological diseases: a new dose of rejuvenation injected","volume":"14","author":"Mitrecic","year":"2011","journal-title":"Rejuvenation Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0630","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","article-title":"Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate","volume":"1","author":"Morizane","year":"2013","journal-title":"Stem Cell Reports"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0635","article-title":"Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP\/PS1 Alzheimer mice","author":"Naaldijk","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0640","doi-asserted-by":"crossref","first-page":"595410","DOI":"10.1155\/2012\/595410","article-title":"Gene regulation systems for gene therapy applications in the central nervous system","volume":"2012","author":"Naidoo","year":"2012","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0645","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrg2985","article-title":"Ex vivo gene transfer and correction for cell-based therapies","volume":"12","author":"Naldini","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0650","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0655","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mrdd.1022","article-title":"Juvenile onset Huntington's disease\u2014clinical and research perspectives","volume":"7","author":"Nance","year":"2001","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0660","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0665","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/rccm.201206-1072OC","article-title":"Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis","volume":"187","author":"Nichols","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-2013-1918","article-title":"Genetic engineering of stem cells for enhanced therapy","volume":"73","author":"Nowakowski","year":"2013","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0675","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5966\/sctm.2014-0212","article-title":"Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis","volume":"4","author":"Oh","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0680","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/mds.26426","article-title":"Trophic factors for Parkinson's disease: to live or let die","volume":"30","author":"Olanow","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0685","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nm0898-963","article-title":"Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease","volume":"4","author":"Palfi","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0690","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0168-0102(01)00242-5","article-title":"Protection of nigral neurons by GDNF-engineered marrow cell transplantation","volume":"40","author":"Park","year":"2001","journal-title":"Neurosci. Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0695","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3858\/emm.2009.41.7.054","article-title":"Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice","volume":"41","author":"Park","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0700","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00439-016-1699-x","article-title":"Genome-editing technologies for gene correction of hemophilia","volume":"135","author":"Park","year":"2016","journal-title":"Hum. Genet."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0705","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00401-015-1513-1","article-title":"Astrocytes: a central element in neurological diseases","volume":"131","author":"Pekny","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0710","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.571147","article-title":"Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system","volume":"204","author":"Perlow","year":"1979","journal-title":"Science"},{"issue":"3","key":"10.1016\/bs.pbr.2016.11.003_bb0715","article-title":"Microglia, Microbiol. Spectr","volume":"4","author":"Perry","year":"2016"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0720","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamaneurol.2015.4321","article-title":"Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1\/2 and 2a clinical trials","volume":"73","author":"Petrou","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0725","doi-asserted-by":"crossref","first-page":"5.67.1","DOI":"10.1002\/0471141755.ph0567s69","article-title":"Rodent models of amyotrophic lateral sclerosis","volume":"69","author":"Philips","year":"2015","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0730","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/sj.gt.3302847","article-title":"Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells","volume":"14","author":"Pineda","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-10-1","article-title":"Clinical application of stem cell therapy in Parkinson's disease","volume":"10","author":"Politis","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0740","doi-asserted-by":"crossref","first-page":"128ra41","DOI":"10.1126\/scitranslmed.3003391","article-title":"Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts","volume":"4","author":"Politis","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0745","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/mt.2016.12","article-title":"Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in Huntington's disease mouse models","volume":"24","author":"Pollock","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0750","doi-asserted-by":"crossref","first-page":"839638","DOI":"10.1155\/2015\/839638","article-title":"Poststroke cell therapy of the aged brain","volume":"2015","author":"Popa-Wagner","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0755","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbmt.2010.04.014","article-title":"Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study","volume":"17","author":"Prasad","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0760","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0765","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/emmm.201302878","article-title":"Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons","volume":"6","author":"Proschel","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/bs.pbr.2016.11.003_bb0770","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/bpa.12432","article-title":"Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF","volume":"26","author":"Puigdellivol","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0775","article-title":"Lentivirus mediated correction of Artemis-deficient severe combined immunodeficiency","author":"Punwani","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0780","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0785","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0790","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0795","article-title":"First CRISPR clinical trial gets green light from US panel","volume":"534","author":"Reardon","year":"2016","journal-title":"Nature News"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0800","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1089\/10430340260355383","article-title":"Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease","volume":"13","author":"Regulier","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0805","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1227\/01.NEU.0000343524.45387.9E","article-title":"Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform","volume":"65","author":"Riley","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0810","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1227\/NEU.0000000000000156","article-title":"Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes","volume":"74","author":"Riley","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0815","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1126\/science.3201248","article-title":"Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression","volume":"242","author":"Rosenberg","year":"1988","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0820","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2014.11.060","article-title":"Transplantation of fetal ventral mesencephalic progenitor cells overexpressing high molecular weight fibroblast growth factor 2 isoforms in 6-hydroxydopamine lesioned rats","volume":"286","author":"Rumpel","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0825","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/scd.2008.0411","article-title":"Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease","volume":"18","author":"Sadan","year":"2009","journal-title":"Stem Cells Dev."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0830","doi-asserted-by":"crossref","DOI":"10.1371\/4f7f6dc013d4e","article-title":"Intrastriatal transplantation of neurotrophic factor-secreting human mesenchymal stem cells improves motor function and extends survival in R6\/2 transgenic mouse model for Huntington's disease","author":"Sadan","year":"2012","journal-title":"PLoS Curr."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0835","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.expneurol.2011.12.045","article-title":"Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease","volume":"234","author":"Sadan","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0840","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/STROKEAHA.112.656900","article-title":"Neural stem cells genetically modified to overexpress cu\/zn-superoxide dismutase enhance amelioration of ischemic stroke in mice","volume":"43","author":"Sakata","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0845","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-0035-1558984","article-title":"Amyotrophic lateral sclerosis: review","volume":"35","author":"Salameh","year":"2015","journal-title":"Semin. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0850","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/cne.23578","article-title":"Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord","volume":"522","author":"Sareen","year":"2014","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0855","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jcyt.2016.01.004","article-title":"Autologous mesenchymal stromal cell transplantation for spinal cord injury: a phase I pilot study","volume":"18","author":"Satti","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0860","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.trsl.2015.09.008","article-title":"Advances in therapeutic CRISPR\/Cas9 genome editing","volume":"168","author":"Savic","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0865","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","article-title":"The cholinergic system in aging and neuronal degeneration","volume":"221","author":"Schliebs","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0870","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/454682a","article-title":"Neuroscience: standard model","volume":"454","author":"Schnabel","year":"2008","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0875","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17482960701856300","article-title":"Design, power, and interpretation of studies in the standard murine model of ALS","volume":"9","author":"Scott","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0880","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0166-2236(03)00031-6","article-title":"Stem and progenitor cells: the premature desertion of rigorous definitions","volume":"26","author":"Seaberg","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0885","first-page":"401","article-title":"Research on Parkinson disease","volume":"102","author":"Slevin","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0890","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/mthe.2002.0646","article-title":"Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts","volume":"6","author":"Sommer","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0895","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.exphem.2008.03.004","article-title":"Isolation and characterization of CD146+ multipotent mesenchymal stromal cells","volume":"36","author":"Sorrentino","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0900","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/stem.1415","article-title":"Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons","volume":"31","author":"Sundberg","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000689","article-title":"GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS","volume":"2","author":"Suzuki","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0910","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/mt.2008.197","article-title":"Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS","volume":"16","author":"Suzuki","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0915","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1093\/hmg\/ddt379","article-title":"Back to the future: how human induced pluripotent stem cells will transform regenerative medicine","volume":"22","author":"Svendsen","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0920","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/exnr.1997.6634","article-title":"Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease","volume":"148","author":"Svendsen","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0925","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0165-0270(98)00126-5","article-title":"A new method for the rapid and long term growth of human neural precursor cells","volume":"85","author":"Svendsen","year":"1998","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0930","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nmeth846","article-title":"A versatile tool for conditional gene expression and knockdown","volume":"3","author":"Szulc","year":"2006","journal-title":"Nat. Methods"},{"issue":"Suppl. 1","key":"10.1016\/bs.pbr.2016.11.003_bb0935","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1227\/01.neu.0000489703.68466.c4","article-title":"133 the development of human embryonic stem cell-derived dopamine neurons for clinical use in Parkinson disease","volume":"63","author":"Tabar","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0940","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/acn3.134","article-title":"Analysis of graft survival in a trial of stem cell transplant in ALS","volume":"1","author":"Tadesse","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0945","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0950","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jnr.10412","article-title":"Engraftment of sorted\/expanded human central nervous system stem cells from fetal brain","volume":"69","author":"Tamaki","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0955","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/1574888X09666140923101110","article-title":"Mesenchymal stem cells: potential in treatment of neurodegenerative diseases","volume":"9","author":"Tanna","year":"2014","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0960","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0965","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neuroscience.2005.03.003","article-title":"Genetically engineered cells with regulatable GABA production can affect after discharges and behavioral seizures after transplantation into the dentate gyrus","volume":"133","author":"Thompson","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0970","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0975","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127302","article-title":"Intra-arterial transplantation of allogeneic mesenchymal stem cells mounts neuroprotective effects in a transient ischemic stroke model in rats: analyses of therapeutic time window and its mechanisms","volume":"10","author":"Toyoshima","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0980","first-page":"563820","article-title":"Foetal cell transplantation for Parkinson's disease: focus on graft-induced dyskinesia","volume":"2015","author":"Tronci","year":"2015","journal-title":"Parkinsons Dis."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0985","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","article-title":"Stem cell therapies in clinical trials: progress and challenges","volume":"17","author":"Trounson","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pbr.2016.11.003_bb0990","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrg.2016.28","article-title":"Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases","volume":"17","author":"Tsai","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/bs.pbr.2016.11.003_bb0995","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/scrt313","article-title":"Clinical translation of human neural stem cells","volume":"4","author":"Tsukamoto","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1000","first-page":"305","article-title":"Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration","volume":"3","author":"Tuszynski","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1010","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/jamaneurol.2015.1807","article-title":"Nerve growth factor gene therapy: activation of neuronal responses in Alzheimer disease","volume":"72","author":"Tuszynski","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/exnr.1998.6998","article-title":"Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation","volume":"156","author":"Vescovi","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1020","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","article-title":"Direct conversion of fibroblasts to functional neurons by defined factors","volume":"463","author":"Vierbuchen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2016.11.003_bb1025","doi-asserted-by":"crossref","first-page":"9907","DOI":"10.1007\/s00253-015-6965-7","article-title":"Lost signature: progress and failures in in vivo tracking of implanted stem cells","volume":"99","author":"von der Haar","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0072-9752(07)01256-0","article-title":"Neuropathology of Huntington's disease","volume":"89","author":"Vonsattel","year":"2008","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1035","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.1038\/srep09621","article-title":"Galectin-1-secreting neural stem cells elicit long-term neuroprotection against ischemic brain injury","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1040","doi-asserted-by":"crossref","first-page":"15012","DOI":"10.1038\/celldisc.2015.12","article-title":"Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson's disease model","volume":"1","author":"Wang","year":"2015","journal-title":"Cell Discov."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.24436","article-title":"Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: a double-blind, randomized, controlled trial","volume":"78","author":"Warren Olanow","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1050","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/glia.22988","article-title":"Targeting microglia for the treatment of Alzheimer's disease","volume":"64","author":"Wes","year":"2016","journal-title":"Glia"},{"key":"10.1016\/bs.pbr.2016.11.003_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2012.11.006","article-title":"The worldwide economic impact of dementia 2010","volume":"9","author":"Wimo","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1060","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.tibtech.2015.06.009","article-title":"piggyBac-ing models and new therapeutic strategies","volume":"33","author":"Woodard","year":"2015","journal-title":"Trends Biotechnol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000124979","article-title":"Neural stem cells improve learning and memory in rats with Alzheimer's disease","volume":"75","author":"Wu","year":"2008","journal-title":"Pathobiology"},{"key":"10.1016\/bs.pbr.2016.11.003_bb1075","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11064-009-0086-6","article-title":"Intrastriatal transplantation of GDNF-engineered BMSCs and its neuroprotection in lactacystin-induced Parkinsonian rat model","volume":"35","author":"Wu","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1080","doi-asserted-by":"crossref","first-page":"27358","DOI":"10.1038\/srep27358","article-title":"Gain of BDNF function in engrafted neural stem cells promotes the therapeutic potential for Alzheimer's disease","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1085","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.tp.0000235532.00920.7a","article-title":"Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats","volume":"82","author":"Xu","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/bs.pbr.2016.11.003_bb1090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neulet.2011.03.017","article-title":"Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats","volume":"494","author":"Xu","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1095","doi-asserted-by":"crossref","first-page":"12409","DOI":"10.1523\/JNEUROSCI.1761-08.2008","article-title":"Transplanted mouse embryonic stem-cell-derived motoneurons form functional motor units and reduce muscle atrophy","volume":"28","author":"Yohn","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(95)00596-I","article-title":"Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease","volume":"691","author":"Yoshimoto","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1105","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2016.11.003_bb1110","first-page":"245","article-title":"Effects of lateral ventricular transplantation of bone marrow-derived mesenchymal stem cells modified with brain-derived neurotrophic factor gene on cognition in a rat model of Alzheimer's disease","volume":"7","author":"Zhang","year":"2012","journal-title":"Neural Regen. Res."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/bs.pbr.2016.11.003_bb1120","doi-asserted-by":"crossref","first-page":"26473","DOI":"10.3390\/ijms161125966","article-title":"Transplantation of human neural stem cells in a parkinsonian model exerts neuroprotection via regulation of the host microenvironment","volume":"16","author":"Zuo","year":"2015","journal-title":"Int. J. Mol. Sci."}],"container-title":["Progress in Brain Research","Functional Neural Transplantation IV - Translation to Clinical Application, Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612316301613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612316301613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T15:15:40Z","timestamp":1749914140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612316301613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128117385"],"references-count":224,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2016.11.003","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}